Biswas S, Kabir S N, Pal A K
Indian Institute of Chemical Biology, Jadavpur, Calcutta, India.
J Reprod Fertil. 1998 Sep;114(1):157-61. doi: 10.1530/jrf.0.1140157.
Nitric oxide (NO) plays an important role in cell signalling in many physiological systems, including reproduction. During pregnancy, oestrogen modulates uterine NO generation, and NO may play an intermediary role in the oestrogen-mediated effects on the uterus. Since oestrogen is actively involved in inducing endometrial receptivity to support the process of implantation, the role of NO in the process of implantation in rats was investigated. N omega-nitro-L-arginine methyl ester (L-NAME), an inhibitor of NO synthase (NOS), was administered in utero with or without sodium nitroprusside (SNP), a generator of NO, on different days during the preimplantation phase of gestation. The status of gestation in respect of implantation failure, endometrial receptivity and embryo development were assessed. L-NAME was administered at various doses (2-5 mg per uterine horn) and on different days of pregnancy (days 2-6 of pregnancy) to optimize the pregnancy terminating dose (absence of implantation site on day 8 of pregnancy) and the effective day of treatment. L-NAME led to failure of implantation when administered at 2.5 mg per uterine horn on day 3 of pregnancy. The characteristic preimplantation permeability changes in the uterus were significantly attenuated and embryo growth was retarded. The L-NAME-mediated effects were significantly reversed when SNP (100 micrograms) was co-administered with L-NAME. These findings suggest a role for NO in the process of implantation. The possible mechanism by which inhibition of the NO-NOS system may interfere with implantation is discussed.
一氧化氮(NO)在包括生殖系统在内的许多生理系统的细胞信号传导中发挥着重要作用。在怀孕期间,雌激素调节子宫内NO的生成,并且NO可能在雌激素对子宫的介导作用中起中介作用。由于雌激素积极参与诱导子宫内膜容受性以支持着床过程,因此研究了NO在大鼠着床过程中的作用。在妊娠植入前阶段的不同日子,将NO合酶(NOS)抑制剂Nω-硝基-L-精氨酸甲酯(L-NAME)经子宫内给药,同时给予或不给予NO生成剂硝普钠(SNP)。评估了妊娠在着床失败、子宫内膜容受性和胚胎发育方面的状况。给予不同剂量的L-NAME(每个子宫角2-5mg)并在妊娠的不同日子(妊娠第2-6天)给药,以优化终止妊娠的剂量(妊娠第8天无着床部位)和有效的治疗日。当在妊娠第3天以每个子宫角2.5mg的剂量给予L-NAME时,导致着床失败。子宫中典型的植入前通透性变化明显减弱,胚胎生长受到抑制。当SNP(100微克)与L-NAME共同给药时,L-NAME介导的作用显著逆转。这些发现表明NO在着床过程中起作用。讨论了抑制NO-NOS系统可能干扰着床的可能机制。